Visible‐Light‐Activated Molecular Machines Kill Fungi by Necrosis Following Mitochondrial Dysfunction and Calcium Overload
Open Access
- 30 January 2023
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 10 (10)
Abstract
Invasive fungal infections are a growing public health threat. As fungi become increasingly resistant to existing drugs, new antifungals are urgently needed. Here, it is reported that 405‐nm‐visible‐light‐activated synthetic molecular machines (MMs) eliminate planktonic and biofilm fungal populations more effectively than conventional antifungals without resistance development. Mechanism‐of‐action studies show that MMs bind to fungal mitochondrial phospholipids. Upon visible light activation, rapid unidirectional drilling of MMs at ≈3 million cycles per second (MHz) results in mitochondrial dysfunction, calcium overload, and ultimately necrosis. Besides their direct antifungal effect, MMs synergize with conventional antifungals by impairing the activity of energy‐dependent efflux pumps. Finally, MMs potentiate standard antifungals both in vivo and in an ex vivo porcine model of onychomycosis, reducing the fungal burden associated with infection.Keywords
This publication has 71 references indexed in Scilit:
- Candida albicanspathogenicity mechanismsVirulence, 2013
- T-2307 Causes Collapse of Mitochondrial Membrane Potential in YeastAntimicrobial Agents and Chemotherapy, 2012
- Comparative analysis ofCandidabiofilm quantitation assaysMedical Mycology, 2012
- Optimizing a Candida Biofilm Microtiter Plate Model for Measurement of Antifungal Susceptibility by Tetrazolium Salt AssayJournal of Clinical Microbiology, 2011
- Efflux-Mediated Antifungal Drug ResistanceClinical Microbiology Reviews, 2009
- Cellular functions of cardiolipin in yeastBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Vacuolar and Plasma Membrane Proton Pumps Collaborate to Achieve Cytosolic pH Homeostasis in YeastJournal of Biological Chemistry, 2008
- In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida , Aspergillus , Fusarium , and Scedosporium SpeciesAntimicrobial Agents and Chemotherapy, 2008
- Standardization of an Experimental Murine Model of Invasive Pulmonary AspergillosisAntimicrobial Agents and Chemotherapy, 2006
- On the origin of mitosing cellsJournal of Theoretical Biology, 1967